EZH2 inhibitors enhance effectiveness of cancer immunotherapies

An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by Weill Cornell Medicine lymphoma researchers.

bonyf exhibits at PLMA Amsterdam on 28-29 May 2024 – Biotech Investments

bonyf NV / Key word(s): Development of Sales/Investment bonyf exhibits at PLMA Amsterdam on 28-29 May 2024 16-Apr-2024 / 15:19 CET/CEST bonyf exhibits at PLMA

April 17, 2024

Heart attack triggers sleep increase to aid recovery

A heart attack can trigger a desire to get more sleep, allowing the heart to heal and reduce inflammation-;and this happens because the heart sends

November 1, 2024

Commure Unveils Free AI Scribe to Enhance Automated Documentation

What You Should Know: – Commure, a leader in healthcare communication solutions unveils Commure Scribe, a free, AI-powered tool that automates documentation and generates SOAP

April 5, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.